# Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
Canonical URL: https://biopharmsignal.com/news/FENC/southpoint-holdings-in-fennec-pharmaceuticals-inc-tsx-fenc
Ticker: FENC
Company: Fennec Pharmaceuticals Inc.
Source: Fennec Pharmaceuticals Inc.
Published: 2025-12-26 22:44 EST
Original Source URL: https://investors.fennecpharma.com
## Summary

NEW YORK , Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025 , pursuant to securities laws, it disposed of beneficial ownership of 1,000,000

## Article Body
NEW YORK , Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025 , pursuant to securities laws, it disposed of beneficial ownership of 1,000,000
## Recent Company News
- 2026-05-21 22:01 EST — [Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting](https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmarkr-at-the-2026-asco-annual-meeting) — Source: Fennec Pharmaceuticals Inc.
- 2026-05-18 20:30 EST — [Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Fennec Pharmaceuticals Inc.
- 2026-05-14 10:30 EST — [Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: Fennec Pharmaceuticals Inc.
- 2026-05-07 10:36 EST — [Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026](https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-14-2026) — Source: Fennec Pharmaceuticals Inc.
- 2026-04-21 20:30 EST — [Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting](https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-acceptance-of-abstracts-at-the-2026-asco-annual-meeting) — Source: Fennec Pharmaceuticals Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)